Literature DB >> 25062171

Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei.

A I Morales1, J Benlliure1, T Kurtukián-Nieto1, K-H Schmidt2, S Verma1, P H Regan3, Z Podolyák4, M Górska2, S Pietri4, R Kumar5, E Casarejos1, N Al-Dahan4, A Algora6, N Alkhomashi4, H Álvarez-Pol1, G Benzoni7, A Blazhev8, P Boutachkov2, A M Bruce9, L S Cáceres2, I J Cullen4, A M Denis Bacelar9, P Doornenbal2, M E Estévez-Aguado1, G Farrelly4, Y Fujita10, A B Garnsworthy4, W Gelletly4, J Gerl2, J Grebosz11, R Hoischen12, I Kojouharov2, N Kurz2, S Lalkovski9, Z Liu13, C Mihai14, F Molina15, D Mücher8, B Rubio15, H Shaffner2, S J Steer4, A Tamii16, S Tashenov2, J J Valiente-Dobón17, P M Walker4, H J Wollersheim2, P J Woods13.   

Abstract

This Letter reports on a systematic study of β-decay half-lives of neutron-rich nuclei around doubly magic (208)Pb. The lifetimes of the 126-neutron shell isotone (204)Pt and the neighboring (200-202)Ir, (203)Pt, (204)Au are presented together with other 19 half-lives measured during the "stopped beam" campaign of the rare isotope investigations at GSI collaboration. The results constrain the main nuclear theories used in calculations of r-process nucleosynthesis. Predictions based on a statistical macroscopic description of the first-forbidden β strength reveal significant deviations for most of the nuclei with N<126. In contrast, theories including a fully microscopic treatment of allowed and first-forbidden transitions reproduce more satisfactorily the trend in the measured half-lives for the nuclei in this region, where the r-process pathway passes through during β decay back to stability.

Year:  2014        PMID: 25062171     DOI: 10.1103/PhysRevLett.113.022702

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  1 in total

1.  Nuclear Data Evaluation for Mass Chain A=217:Odd-Proton Nuclei.

Authors:  Sherif S Nafee; Salem A Shaheen; Amir M Al-Ramady
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.